predictive value of different BP measuring methods (OBPM, ABPM, and HBPM) on the identification of EVA in hypertensive patients. In this study, we assessed the diagnostic accuracy of different BP measurements' methods in the identification of EVA, and we further explored for other possible parameters that may associate with increased arterial stiffness. Moreover, we developed a risk score for EVA prediction in hypertensive patient, the Early Vascular Aging Ambulatory score (EVAAs), based on ambulatory BP values and other CV risk factors.
ΜETHODS

Study population
The study population consisted of 282 consecutive subjects aged ≥18 years old, who referred to the Hypertension-24-hour Ambulatory Blood Pressure Monitoring Center of Excellence, 3rd Internal Medicine Department of Aristotle University, Thessaloniki, Greece. The institutional review board approved the human research protocol. The study's methodology adheres to the principles of the Declaration of Helsinki and all subjects volunteered and gave their informed consent to participate in the study.
Τhe study population included all subjects, who referred to the Hypertension Center for elevated BP from 01 January 2014 to 31 December 2016 and consented to participate to the study. The exclusion criteria for the study were (i) secondary causes of hypertension, (ii) end stage renal disease, (iii) systematic diseases, and (iv) inflammation. All patients that were eligible were accepted to participate in the study. Body mass index (BMI), waist and hip circumference, fasting serum glucose, fasting serum total cholesterol, triglycerides, low density cholesterol, high density cholesterol, and creatinine were also measured in all subjects. Kidney function was evaluated using the estimated glomerular filtration rate, calculated by the abbreviated "modification of diet in renal disease" formula. 16, 17 Lifestyle habits such as smoking and alcohol were also recorded. The presence of diabetes was defined as fasting plasma glucose ≥ 126 mg/dl or 2-hour post-load glucose ≥ 200 mg/dl or hemoglobin A1c ≥ 6.5% 18 or diabetes treatment.
BP measurements: OBPM, HBPM, and ABPM
Office, home, and ambulatory BP measurements were performed in all patients. At initial visit, a trained physician measured office BP 3 times in each subject using a mercury sphygmomanometer with the appropriate size cuff. The measurements were performed according to the 2013 guidelines of European Society of Hypertension and European Society of Cardiology for the BP measurement. 16 At the same day with the first office BP measurements, all subjects underwent ABPM. The Spacelabs 90217 ambulatory BP monitor (Spacelabs, Redmond, WA) was used. The appropriate size cuff was placed around the nondominant arm and 3 measurements were made, along with sphygmomanometric measurements to verify that the average of these values did not differ by more than 5 mm Hg. All subjects were instructed to have a usual activity during the daytime and sleep between 0000 and 0600 hours. Patients were also instructed to keep their arm by the side during the measurements, to avoid intense exercise, and avoid to sleep during daytime. ABPM was performed on a usual working day. Patients who stated that they had not rested or slept during nighttime were excluded from the study (n = 13). After 1 week, when the 7 days of HBPM were completed, the same physician remeasured office BP in each subject. Office BP in the analysis was calculated as the average of 6 office BP measurements.
Home BP monitoring was performed using the validated WatchBP Home device (Microlife AG Swiss, Widnau, Wahlkreis, Switzerland). 19 A trained physician explained the patient how to use the device and gave all the required information for the proper measurement of BP according to the guidelines. 16 The device was scheduled to measure BP twice per day, once in the morning (06:00-09:00) and once in the evening (18:00-21:00). Two BP measurements were performed in each subject during these periods, with 1-minute interval between measurements. Home BP used in the analysis was calculated as the average of the measurements, after discarding the 1st day measurements. Home BP data were downloaded from the device through a personal computer. Participants who provided fewer than 6 days measurements were excluded from the study (n = 4). Finally, after excluding those with unsuccessful ABPM and HBPM, 265 participants were analyzed.
Vascular aging defined from pulse wave velocity analysis
Arterial stiffness was estimated by c-f PWV performed in all patients at initial visit by the same physician. According to the Artery Society and the European Society of Hypertension Working Group on Vascular Structure and Function recommendations, 20 the examination took place in a laboratory with constant temperature at 21 °C. The patients remained in a supine position for at least 10 minutes before the examination. Ten minutes after the first measurement, the same physician repeated the measurement. The average of these 2 measurements was used to calculate c-f PWV. C-f PWV was calculated by dividing the 80% of direct distance between the recording sites (carotid-femoral) with the transit time of the arterial pulse along the distance. 9 The transit time was obtained by the Complior System (Colson, Les Lilas, France) automatically, whereas the distances were measured by the researcher using a centimeter tape. 21 Intra-observer agreement between the c-f PWV measurements was excellent. The mean of the difference of the 2 measurements was extremely low (mean = 0.0053). The limits of agreement were −2.347, 2.357 (Supplementary Figure 1) . EVA was defined as c-f PWV values higher than the expected for age average values according to European population data. 22 
Statistical analysis
Statistical tests were performed using the SPSS version 22.0. All values were expressed as means ± SD. Normality was evaluated with the Kolmogorov-Smirnov or the Shapiro-Wilk test, as appropriate. Intra-observer agreement was calculated in order to identify the agreement of the 2 c-f PWV measurements. Logistic regression analysis was performed to examine relations between BP variables by different methods and EVA. A 2-tailed P value < 0.05 was considered statistically significant. Receiver operating characteristic (ROC) curves were constructed to assess the overall predicting accuracy of different BP measurement methods for EVA. Areas under the curves were compared using STATA 12.0.
An exploratory analysis of the parameter distribution showed that there is similarity in density of measurements for all BP variables in the 2 groups (EVA and no EVA), as shown in Supplementary Figure 2 . As a result, a general linear model would not be able to fit on data and make accurate predictions about the EVA. The model was developed using a supervised machine learning classification algorithm, Random Forest, with R version 3.3.3. Random Forest is an ensemble method for tree type classifiers (h(x,Θ_k), k = 1, …) where Θk is the independent identically distributed random vectors for input x. In ensemble methods, many classifiers are generated and their results are aggregated through a voting process. 23 Random Forest algorithm is implemented by creating multiple classification and regression trees (CART)-like trees. A bootstrapped sample method is used to train each tree and a subset of the input variables, which are randomly selected, is used to define splits for each node. Each tree of these constitutes a unit vote for the most popular class for input x. Classification result is determined by the majority vote of the trees. 24 Consequently, the classifier is not sensitive to the noise of data, handling the outliers efficiently, and has the ability to produce accurate results. Random Forest classifier performs implicit feature selection using a subset of the stronger variables. The optimal split for each node τ within binary trees T of the Random Forest is sought using the Gini impurity i(τ). Gini impurity is a computationally efficient approximation to the entropy, assessing the performance of a potential split, separating the samples of the 2 classes in a node. Gini importance indicates the frequency of a feature used for splitting nodes, and the overall discriminative value of this feature for the classification problem. 25 EVA classification model was created using 50 CART-like trees and 2 mtry features as Random Forest parameters. Supplementary Figure 3 shows the Random Forest training workflow and Supplementary Figure 4 shows a sample tree from EVA classification model. Evaluation of the model was performed with the 8-fold cross validation method, for assessing how the results of a model could generalize an independent data set. 26, 27 The cross validation performed by splitting the data set into 8 weighted sets. Seven training data sets of the study patients, usually called "known data, " were used to train the Random Forest model. The 8th data set was used as unknown data to the model in order to generalize the results to an independent data set. This procedure repeated 8 times to make sure that the algorithm provide accurate results and the model is not overfitting to data. The margin function for given ensemble of classifiers h 1 (x), h 2 (x), ..., h k (x), and a training set from the distributions of the random vector Y,X defined as Statistically significant values are presented with bold. Abbreviations: BMI, body mass index; c-f PWV, carotid-femoral pulse wave velocity; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; EVA, early vascular aging; HR, heart rate; SBP, systolic blood pressure.
a P value denotes the P value comparing patients with no EVA with patients with EVA.
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where I(.) is the indicator function. Classification is more confidence as the margin is increasing. 23 The procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Helsinki Declaration of 1975 (as revised in 1983).
RESULTS
Descriptive statistics
Demographic data of the population are summarized in Table 1 . Patients with EVA were younger, having higher 24-hour ambulatory BP values despite similar office and home BP values.
Regression analysis
In the univariate analysis, EVA showed significant correlations with mean 24-hour systolic blood pressure (SBP), mean 24-hour diastolic blood pressure (DBP), mean 24-hour heart rate (HR), mean office SBP, and mean office HR ( Table 2) . No relationship was found for mean home SBP, mean home DBP, mean home HR, and mean office DBP. Additional risk factors, which have been also examined, but were not statistically significant were BMI, gender, treatment (yes-no), waist, hip, smoking, triglycerides, low density cholesterol, and high density cholesterol.
Linear correlations and an adjusted regression model with cf-PWV treated as a continuous variable is shown in Table 3 .
In treated subjects, we further studied the possible role of beta blocker treatment in c-f PWV and EVA, but we could not identify significant differences compared to patients treated with other drug classes (Supplementary Figure 5) .
Diagnostic accuracy
According to the ROC curves, the prediction of EVA was statistically significant only for SBP derived from ABPM (daytime SBP, home SBP, and office SBP). The area under the Figure 1 .
Model evaluation
This study considered multiple risk factors to develop a risk score for the prediction of EVA with Random Forest algorithm, including 24-hour SBP, 24-hour DBP, 24-hour HR, age, sex, BMI, diabetes mellitus (yes-no), and estimated glomerular filtration rate (modification of diet in renal disease). Additional risk factors that have also been examined but were not used in the model, because they were not statistically significant, were treatment, waist, hip, smoking, triglycerides, low density cholesterol, and high density cholesterol. Each of the variables contributes to the final score as shown in the Gini importance of selected variables according to Random Forest classifier (Figure 2 ). The accuracy, sensitivity, and specificity for every round of 8-fold cross validation are shown in Table 4 . The EVAAs shows the probability of EVA with 0.82 accuracy, 0.84 sensitivity, and 0.78 specificity. The free APP link for the measurement of EVAAs is https://medapps.shinyapps.io/evaas/. (Figure 3) 
DISCUSSION
This study compared the performance of BP measurements at office, home, and ABPM for the diagnostic accuracy of EVA as assessed from c-f PWV measurements. The study findings suggested that in individuals referred for hypertension, average 24-hour SBP is a better determinant of EVA compared to home or clinic BP measurements. Using the study results, a new score for predicting EVA (EVAAs) was introduced by using the following parameters (i) 24-hour Hypertension is a strong determinant of EVA. 3, [28] [29] [30] In this study, we found a closer relation of 24-hour SBP compared to both OBPM and HBPM to predict c-f PWV. Studies comparing the predictive value of the BP measurement methods in order to identify which measurement can better predict c-f PWV are limited, whereas to the best of our knowledge, no study assessed the predictive value of BP measurement methods on the identification of EVA. Two studies compared ABPM or HBPM with OBPM. Stergiou et al. 14 compared the 3 different BP measurement methods in predicting hypertensive target organ damage (left-ventricular mass index, urinary albumin excretion rate, and c-f PWV). The results of this study showed no statistically significant correlation between c-f PWV and different BP measurements, a finding that is in contrast with studies suggesting a relationship of arterial stiffness with SBP. 3, 7 A possible explanation was that the study population had a very low incidence of target organ damage. Niiranen et al. 13 compared home BP measurements with office BP measurements and found that home BP was a stronger determinant of arterial stiffness compared to office BP. A meta-analysis for the comparison of the different BP measurement methods in the prediction of target organ damages used only 3 studies for the pooled outcome of PWV; only one of this compared ABPM to HBPM (the one previously mentioned). 14, 31 EVAAs, a new score for predicting EVA based on 24-hour BP values and classic CV risk factors, was developed using this study's results. Beyond hypertension, other CV risk factors have been linked either with EVA or with CV mortality and morbidity. Diabetes mellitus, obesity, and metabolic syndrome, as well as impaired kidney function, are known determinants of c-f PWV and CV risk factors. [32] [33] [34] [35] [36] [37] [38] Risk scores for predicting target organ damage, such as common carotid artery intima-media thickness or c-f PWV, directly from 24-hour BP have been suggested. Increase in the 24-hour rate of SBP variation was associated to an increment in common carotid artery intimamedia thickness. 39 ABPM parameters have also been used to calculate ambulatory arterial stiffness index (AASI), a predictor of arterial stiffness, as elasticity in the arterial system influences the height of the DBP and its relation to SBP. 40 The latter score had the disadvantage that important predictors of vascular age have not been considered. AASI is strongly dependent on the degree of nocturnal BP fall in hypertensive patients, and there is no significant relation between AASI and left ventricular mass after proper adjustment for confounders and the relation between AASI and a widely accepted measure of aortic stiffness, such as pulse wave velocity, is weak and importantly affected by other factors. 41 However, studies have shown significant relationship between AASI and CV hard end points. [42] [43] [44] The EVAAs developed in this study for EVA classification showed that the combination of age, sex, BMI, diabetes mellitus, and estimated glomerular filtration rate with ABPM parameters provides high accuracy. EVAAs may classify patients from EVA using easily measured variables and could be used for risk stratification. Furthermore, EVAAS may identify patients requiring further diagnostic evaluation for EVA and could be a useful tool in the evaluation of the high-risk patient with regard to prediction of CV disease.
The results of this study should be interpreted taking into account potential strengths and limitations. One limitation of the study population is the relative small population sample but consecutive patients were included. The study included only patients of Caucasian origin and the results may not be extended to other ethnicities. Significant strength of the study is that the developed EVAAs score has a great accuracy, sensitivity, and specificity. To minimize the detection of bias, one investigator was responsible for the BP measurements and a blinded investigator performed the c-f PWV measurements and the calculation of EVA.
The findings of this study suggest that ABPM is useful for predicting EVA. A risk score for EVA using 24-hour BP parameters and other CV risk factors has been developed based on the study findings. This score may identify patients with available ABPM values who would further need to measure c-f PWV to confirm EVA. The accuracy of the EVAAs model should be further studied for its accuracy in larger-scale population samples, as well for predicting hard end points in prospective studies. Moreover, EVAAs should be evaluated for its performance on other hypertensive target organ damage, such as left ventricular hypertrophy and microalbuminuria. Finally, in future the prediction of EVA, assessed by EVAAs, could be used to guide early lifestyle or pharmaceutical interventions in order to prevent future CV events.
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